Cited by 229Animal testing and alternativesImmunotoxicology and immune responsesCarcinogens and Genotoxicity Assessment

The US Federal Tox21 Program: A strategic and operational plan for continued leadership

Open access
Thomas, Russell·2018·ALTEX

Abstract

The traditional approaches to toxicity testing have posed multiple challenges for evaluating the safety of commercial chemicals, pesticides, food additives/contaminants, and medical products.The challenges include number of chemicals that need to be tested, time and resource intensive nature of traditional toxicity tests, and unexpected adverse effects that occur in pharmaceutical clinical trials despite the extensive toxicological testing.Over a decade ago, the U.S. Environmental Protection Agency (EPA), National Toxicology Program (NTP), National Center for Advancing Translational Sciences (NCATS), and the Food and Drug Administration (FDA) formed a federal consortium for "Toxicology in the 21st Century" (Tox21) with a focus on developing and evaluating in vitro high-throughput screening (HTS) methods for hazard identification and providing mechanistic insights.The Tox21 consortium generated data on thousands of pharmaceuticals and datapoor chemicals, developed better understanding of the limits and applications of in vitro methods, and enabled incorporation of HTS data into regulatory decisions. To more broadly address the challenges in toxicology, Tox21 has developed a new strategic and operational plan that expands the focus of its research activities. The new focus areas include developing an expanded portfolio of alternative test systems, addressing technical limitations of in vitrotest systems, curating legacy in vivo toxicity testing data, establishing scientific confidence in the in vitrotest systems, and refining alternative methods for characterizing pharmacokinetics and in vitro assay disposition.The new Tox21 strategic and operational plan addresses key challenges to advance toxicology testing and will benefit both the organizations involved and the toxicology community.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.14573/altex.1803011

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. NRC. 1984 Toxicity testing: Strategies to determine needs and priorities. Washington, D.C.: National Research Council of the National Academies. 25032410

Cited by

Sorted by citations

Authors
Thomas, R.
Affiliations
Environmental Protection Agency (US)
Corresponding author
Thomas, Russell
Venue
ALTEX
Publisher
ALTEX Edition
Published
2018
Volume
35
Issue
2
Pages
163-168
ISSN
  • 0946-7785 (ISSN-L)
  • 1868-596X
OpenAlex
W2790282224
Cited by
229
References
29
Citations by year
2026: 30 · 2025: 29 · 2024: 27 · 2023: 29 · 2022: 36 · 2021: 16 · 2020: 28 · 2019: 27 · 2018: 7
FWCI
28.63
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • ALTEX (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institutes of Health
Topics
  • Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
Keywords
Tox21, high-throughput screening, in vitro toxicity testing, alternative test methods, hazard identification, chemical safety assessment, regulatory toxicology, pharmacokinetics, data curation, pharmaceuticals, data-poor chemicals
MeSH terms
Animals, Animal Testing Alternatives, Cooperative Behavior, Humans, Leadership, Pharmacokinetics, United States, United States Environmental Protection Agency, United States Food and Drug Administration, Toxicity Tests, High-Throughput Screening Assays, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review